An R2 non-neuroinvasive herpes simplex virus type 2 vaccine

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/234/30/24

Funding

  • Thyreos, Inc. (1001 NWU // 1R42AI177202-01)
  • National Institute of Allergy and Infectious Diseases (1001 NWU // 1R42AI177202-01)